A new push is emerging to introduce meat products to the U.S. food supply that have come from mRNA-vaccinated animals.
As Slay News has previously reported, pharmaceutical companies have already been pushing for cattle and pigs used in the U.S. meat supply to receive mRNA shots.
However, this list is expanding amid demands for gene therapy technology to be more widely used in foods for American consumption.
Shrimp has now become the latest food source targeted for mRNA vaccines.
An Israeli biotechnology company seeking to bring mRNA vaccines to shrimp farming has raised $8.25 million from a group of venture capitalists.
The company, ViAqua, is seeking to promote and improve animal health in marine species through its orally administered RNA-particle platform.
ViAqua created an RNA-based vaccine product that uses ribonucleic acid interference (RNAi) to manipulate gene expression in shrimp.
RNAi is a biological process where RNA molecules are used to inhibit gene expression or translation by neutralizing targeted mRNA molecules.
The vaccine comes in the form of a coated feed supplement designed to enhance resistance to white spot syndrome virus (WSSV).
WSSV is a viral infection that causes an annual loss of about $3 billion and a 15 percent